Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC14631 SP2509

    HCI-2509, LSD1 Inhibitor VII

    A reversible inhibitor of LSD1
  3. GC11574 HPOB A potent and selective inhibitor of HDAC6
  4. GC12348 Ro 3306

    2-[[(噻吩-2-基)甲基]氨基]-5-[1-(喹啉-6-基)甲-(Z)-亚基]噻唑-4-酮

    An inhibitor of Cdk1
  5. GC17262 Pifithrin-β

    5,6,7,8-四氢-2-(4-甲基苯基)-咪唑并[2,1-B]苯并噻唑,PFT β; Cyclic Pifithrin-α

    An inactivator of p53
  6. GC10021 CPI-360 A selective EZH2 inhibitor
  7. GC11784 LCZ696

    沙库必曲/缬沙坦; LCZ696

    A dual angiotensin II receptor antagonist and neprilysin inhibitor
  8. GC14794 PF-06463922

    劳拉替尼; PF-06463922

    An orally available inhibitor of ALK and ROS1
  9. GC15805 UMI-77 A selective Mcl-1 inhibitor
  10. GC12247 K-Ras(G12C) inhibitor 12 An allosteric inhibitor of oncogenic K-Ras(G12C)
  11. GC11973 HSP990 (NVP-HSP990)

    HSP-990

    An Hsp90 inhibitor
  12. GC16511 OTS964 A TOPK inhibitor
  13. GC14188 Z-YVAD-FMK Z-YVAD-FMK 是一种具有抗炎和抗肿瘤活性的细胞渗透性 caspase-1 和 -4 抑制剂。
  14. GC18021 Ac-YVAD-CHO

    乙酰基-酪氨酰-缬氨酰-丙氨酰-天冬氨醛,L-709049

    An inhibitor of caspase-1
  15. GC16479 UC 112

    5-[(苯基甲氧基)甲基]-7-(1-吡咯烷基甲基)-8-喹啉醇

    UC 112 是一种新型强效 IAP(凋亡抑制剂)抑制剂;有效抑制两种人黑色素瘤(A375 和 M14)和两种人前列腺(PC-3 和 DU145)癌细胞系的细胞生长(IC50\u003d0.7-3.4 uM)。
  16. GC11971 LY2857785 A Cdk9 inhibitor
  17. GC12178 G-749

    G-749

    An FLT3 kinase inhibitor
  18. GC11834 Epibrassinolide

    表油菜素内酯; 24-Epibrassinolide; B1105; BP55

    A brassinosteroid with protective effects
  19. GC11990 TCS-PIM-1-4a

    5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮,SMI-4a

    TCS-PIM-1-4a (SMI-4a) 是一种泛 Pim 激酶抑制剂,通过激活 AMPK 来阻断 mTORC1 的活性。 TCS-PIM-1-4a 可杀死多种髓系和淋巴系细胞系(IC50 值范围为 0.8 μM 至 40 μM)。
  20. GC15036 Raltegravir potassium salt

    雷特格韦钾盐; MK 0518 potassium

    An HIV-1 integrase inhibitor
  21. GC10334 INH6

    N-[4-(2,4,6-三甲基苯基)-2-噻唑基]苯甲酰胺

    A Hec1/Nek2 inhibitor
  22. GC11445 YH239-EE A prodrug form of YH 239
  23. GC17067 LDC000067

    (3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺,LDC067

    A Cdk9 inhibitor
  24. GC10666 CGP 57380

    N3-(4-氟苯基)-1H-吡唑并[3,4-D]嘧啶-3,4-二胺

    Inhibitor of MAPK-interacting kinase1
  25. GC16713 HS-173 A PI3K inhibitor
  26. GC10098 (S)-10-Hydroxycamptothecin

    10-羟基喜树碱; 10-HCPT; 10-Hydroxycamptothecin

    A DNA topoisomerase I inhibitor
  27. GC17167 SM-164 A cell-permeable Smac mimetic
  28. GC14853 TC ASK 10 A inhibitor of ASK1
  29. GC11985 SC 66 A dual inhibitor of Akt
  30. GC14561 SCH 529074 An activator of p53
  31. GC16597 Alda 1

    N-(1,3-苯并二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺

    A selective ALDH2 agonist

  32. GC14233 BIO-acetoxime

    6-溴靛玉红-3'-丙酮肟,BIA

    A potent, selective inhibitor of GSK3α/β
  33. GC16853 7,8-Dihydroxyflavone

    7,8-二羟基黄酮

    7,8-Dihydroxyflavone(7,8-二羟基黄酮)是一种高亲和力酪氨酸激酶受体B(TrkB)激动剂,IC50值为0.26μM 。
  34. GC11710 CFM 4 CFM 4 是 CARP-1/APC-2 结合的有效小分子拮抗剂。 CFM 4 阻止 CARP-1 与 APC-2 结合,导致 G2M 细胞周期停滞,并诱导细胞凋亡,IC50 范围为 10-15 μM. CFM 4 还抑制耐药人类乳腺癌细胞的生长。
  35. GC11869 SZL P1-41 SZL P1-41是一种特异性S期激酶相关蛋白2(Skp2)抑制剂。
  36. GC15104 (R)-(+)-Etomoxir sodium salt

    (R)-(+)-乙莫克舍钠盐,(R)-(+)-Etomoxir sodium salt

    (R)-(+)-Etomoxir sodium salt(Etomoxir; ETO)是一种用于代谢和心血管疾病的小分子,经酶转化为活性抑制剂乙托莫西里尔辅酶a (IC50 约为0.01-0.70 µM)后,对CPT-1a和CPT-1b的抑制表现出纳摩尔效价。
  37. GC10389 ERB 041

    普林贝瑞; ERB-041

    An ERβ agonist
  38. GC11141 BTZO 1 An antioxidant response element activator with cardioprotective activity
  39. GC14817 Salermide A sirtuin inhibitor
  40. GC16167 K 858 An inhibitor of Eg5
  41. GC17491 CITCO An agonist of human CAR
  42. GC10195 Z-Guggulsterone

    孕二烯二酮

    Z-Guggulsterone 是阿育吠陀药用植物 Commiphora mukul 的一种成分,在体外和体内抑制血管生成,IC50 值为 1740、1000、220 和 >; 50000 nM 用于糖皮质激素、盐皮质激素、雄激素和法尼醇 X 受体 。
  43. GC16711 PNU 74654 An inhibitor of β-catenin/Wnt signaling
  44. GC16948 Valinomycin

    缬氨霉素,NSC 122023

    缬霉素Valinomycin是一种十二肽抗生素,从几种链霉菌菌株中获得。
  45. GC17881 AGK 2

    2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺

    AGK2是一种选择性的SIRT2 抑制剂,IC50为3.5 µM。
  46. GC13568 SecinH3 A selective inhibitor of cytohesins
  47. GC18069 Cardamonin

    小豆蔻明; (E)-Cardamomin; (E)-Alpinetin chalcone

    A chalconoid with anti-inflammatory and anti-tumor activity

  48. GC17658 Guggulsterone

    香胶甾酮; Z/E-Guggulsterone

    Guggulsterone 是一种植物甾醇,来自于 Commiphora wightii 的树胶树脂。 Guggulsterone 通过下调抗凋亡基因产物(IAP1、xIAP、Bfl-1/A1、Bcl-2、cFLIP 和 survivin),调节细胞周期蛋白(cyclin D1 和c-Myc),激活半胱天冬酶和 JNK,抑制 Akt。 Guggulsterone 是一种法尼醇 X 受体 (FXR) 拮抗剂,可降低 CDCA 诱导的 FXR 活化,对 Z- 和 E-Guggulsterone 的 IC50 分别为 17 和 15 μM。
  49. GC10820 Rottlerin

    粗糠柴苦素,Mallotoxin; NSC 56346; NSC 94525

    An inhibitor of PKCδ and other protein kinases
  50. GC10291 SCH 79797 dihydrochloride An antagonist of PAR1
  51. GC13168 AG 825

    酪氨酸磷酸化抑制剂AG825,Tyrphostin AG-825

    An inhibitor of Her2/Neu tyrosine kinase activity

Items 2051 to 2100 of 2733 total

per page

Set Descending Direction